Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
MIRA Pharmaceuticals, Inc. (MIRA) had Return on Equity of -356.98% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.85M |
|
-- |
|
-- |
|
$8.02M |
|
$-8.02M |
|
$0.17M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-8.02M |
|
$-8.02M |
|
15.44M |
|
15.44M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$2.89M |
|
-- |
|
$0.04M |
|
$2.92M |
|
$0.72M |
|
-- |
|
-- |
|
$0.72M |
|
$2.20M |
|
$2.20M |
|
$2.20M |
|
16.56M |
|
| Cash Flow Statement Financials | |
$-5.56M |
|
-- |
|
$3.79M |
|
$4.60M |
|
$2.83M |
|
$-1.77M |
|
$1.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-356.98% |
-356.98% |
|
-268.64% |
|
-356.98% |
|
$0.13 |
|
$-0.36 |
|
$-0.36 |
|